Essential drugs list to soon include commonly used hygiene productsThe government had in 2019 decided to widen the basket of NLEM by including health and hygiene products. However, due to Covid-19 nothing c...
Anti-diabetes drugs and patented antivirals to get cheaper, NLEM notifiedFor the first time, patented drugs like anti-TB bedaquiline and delamanid, anti-HIV Dolutegravir and anti-hepatitis C daclatasvir are also ...
Pharma Industry staring at 30-40 bps hit on updated NLEMManchanda added that the anti-infectives treating HIV, TB and drug cessation treatments in the list doesn't have a major impact on margins ...
Diabetes, patented TB, HIV drugs enter essential listPopular anti-diabetes drug teneligliptin, insulin glargine injection, Common antibiotics like meropenem, Cefuroxime have been included in t...
Essential medicines list: Govt adds 34 new drugs, drops 26; all you need to knowSeveral anti-cancer drugs, antibiotics and vaccines will now become more affordable as they are among 34 new additions to the National List...
Brokerages lower Wockhardt's target price after USFDA import alert on Chikalthana plantThe USFDA import alert on Wockhardt's second plant will have a negative impact on the pharma major, say brokerages.
JM Financial puts buy on Aurobindo PharmaJM Financial has upgraded Aurobindo Pharma to ‘buy’ with a target price of Rs207 mainly due to attractive valuation post the recent stock c...
- Nectar Life gets Japan’s nod for Cefuroxime; stock up
Nectar Lifesciences has received approval from the Japanese MOH for Cefuroxime Axetil. The company is expecting business potential of $ 10m...
- Orchid gets nod from USFDA for Cefuroxime Axetil tablets
Orchid Chemicals & Pharmaceuticals has received approval from USFDA for its abbreviated new drug application for Cefuroxime Axetil tablets.
- Ranbaxy Labs receives USFDA for Cefuroxime Axetil
Ranbaxy Laboratories has received approval from the US Food and Drug Administration to manufacture and market Cefuroxime Axetil for Oral Su...
- It's advantage consumers as top drug brands face price cut
Consumers using blockbuster drug brands are set to benefit more from the government’s proposed drug pricing formula.
- Venus launches new drug in anti-infective segment
Venus Remedies Ltd on Wednesday said it has launched Mucomelt-Forte, an anti-biotic in the domestic market, further enhancing its focus on ...
- Paswan slashes prices of 886 drugs
The list includes anti-diabetic pills, antibiotics, cough syrups, pain killers and anti-hypertensives.
- Ranbaxy, Dr Reddy's get generic shot
Drug majors Dr Reddy’s Laboratories (DRL) and Ranbaxy have scored a victory for their US businesses.